Jack Yalowich

Professor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Molecular Biology Molecular Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jack Yalowich is a Professor at The Ohio State University in the United States. His research focuses on the mechanisms of drug resistance in leukemia and the development of novel bacterial topoisomerase inhibitors. Recent publications include studies on CRISPR/Cas9 gene editing techniques and the actions of topoisomerase inhibitors against various bacterial strains.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Mark Mitton-Fry

Associate Professor

Ohio State University

UNITED STATES

View details

Neil Osheroff

Vanderbilt University School of Medicine

UNITED STATES

View details

Craig McElroy

Research Assistant Professor

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jack Yalowich

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Circumvention of Topoisomerase IIα Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells

Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks

Novel bacterial topoisomerase inhibitors: unique targeting activities of amide enzyme-binding motifs for tricyclic analogs

Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβExpression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide

Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα

Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with in Vivo Efficacy against MRSA

CRISPR/Cas9 Genome Editing of the Human Topoisomerase II<i>α</i> Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells.

Novel bacterial topoisomerase inhibitors derived from isomannide.

Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus

Effects of DNA topoisomerase IIα splice variants on acquired drug resistance.

Collaborators (3)

Mark Mitton-Fry

Neil Osheroff

Craig McElroy

Make your next move.